The Philippine Competition Commission , in compliance with President Ferdinand “Bongbong” R. Marcos Jr.’s directive, has vowed to ensure fair competition in the pharmaceutical market.
It is worth noting that the Philippines is known to have one of the highest costs of medicines in Asia. The competition watchdog stressed that the production of unbranded generic medicines lags behind, even relative to other developing countries. Moreover, Bernabe said, “the Commission has been consistently monitoring and looking into curtailing possible anti-competitive situations, including cartels, that may exist in the different segments of the supply chain of pharmaceutical products.”
With this, he said that as the country continues to face the challenges of the pandemic and rebuild, the PCC commits to the removal of anticompetitive practices that derail the recovery process.
Portugal Últimas Notícias, Portugal Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
DTI, PCC to ensure viability of pharma industryIn a statement, PCC Officer-in-Charge Atty. Johannes R. Bernabe said the agency shared the vision of the President in his first SONA for more accessible and lower-priced medicines for Filipinos by ensuring fair competition in the pharmaceutical market.
Consulte Mais informação »
Cebu2World Development assures relocated vendors of ‘better’ experience at interim marketCEBU CITY, Philippines -- The Cebu2World Development, Inc., in a statement released on Tuesday, July 26, 2022, reassured relocated Carbon Public Market vendors that they and their customers will
Consulte Mais informação »
DTI, PCC to ensure viability of pharma industryIn a statement, PCC Officer-in-Charge Atty. Johannes R. Bernabe said the agency shared the vision of the President in his first SONA for more accessible and lower-priced medicines for Filipinos by ensuring fair competition in the pharmaceutical market.
Consulte Mais informação »